DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 148 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2015. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,923,000 | -56.4% | 1,246,397 | +15.9% | 0.00% | -50.0% |
| Q3 2016 | $11,280,000 | -23.6% | 1,075,267 | +6.1% | 0.00% | -33.3% |
| Q2 2016 | $14,772,000 | -19.2% | 1,013,173 | +6.6% | 0.00% | -25.0% |
| Q1 2016 | $18,293,000 | -23.9% | 950,782 | -4.5% | 0.00% | -33.3% |
| Q4 2015 | $24,047,000 | +2.1% | 995,307 | +3.7% | 0.01% | 0.0% |
| Q3 2015 | $23,545,000 | +29.7% | 959,461 | +23.8% | 0.01% | +50.0% |
| Q2 2015 | $18,152,000 | +3.5% | 774,887 | -0.9% | 0.00% | 0.0% |
| Q1 2015 | $17,532,000 | +43.6% | 781,629 | +8.0% | 0.00% | +33.3% |
| Q4 2014 | $12,205,000 | – | 723,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |